17-β-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cells

Molecular Vision

Volumn 18, Issue , 2012, Pages 1115-1122

  Wang, Changjun ^a   Shi, Xin ^a   Chen, Xiaoyi ^b   Wu, Han ^a   Zhang, Huina ^a   Xie, Jiajun ^a   Yang, Xianyan ^b   Gou, Zhongru ^b   Ye, Juan ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ESTRADIOL; INTERLEUKIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPEROSMOLARITY; INTERLEUKIN 1 GENE; INTERLEUKIN 6 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR NECROSIS FACTOR ALPHA GENE;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE, TRANSFORMED; CORNEA; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; ESTRADIOL; GENE EXPRESSION; HUMANS; IMIDAZOLES; INTERLEUKIN-1; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; OSMOLAR CONCENTRATION; OSMOTIC PRESSURE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PYRIDINES; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863310919     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 2009; 3:405-12. [PMID: 19688028]
2. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136:318-26. [PMID: 12888056]
3. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol 2009; 127:763-8. [PMID: 19506195]
4. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000; 78:146-53. [PMID: 10794246]
5. Suzuki T, Kinoshita Y, Tachibana M, Matsushima Y, Kobayashi Y, Adachi W, Sotozono C, Kinoshita S. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res 2001; 22:28-33. [PMID: 11402376]
6. Jensen AA, Higginbotham EJ, Guzinski GM, Davis IL, Ellish NJ. A survey of ocular complaints in postmenopausal women. J Assoc Acad Minor Phys 2000; 11:44-9. [PMID: 10953544]
7. Piwkumsribonruang N, Somboonporn W, Luanratanakorn P, Kaewrudee S, Tharnprisan P, Soontrapa S. Effectiveness of hormone therapy for treating dry eye syndrome in postmenopausal women: a randomized trial. J Med Assoc Thai 2010; 93:647-52. [PMID: 20572368]
8. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone Replacement Therapy and Dry Eye Syndrome. JAMA 2001; 286:2114-9. [PMID: 11694152]
9. The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007; 5:75-92. [PMID: 17508116]
10. Murube J. Tear Osmolarity. Ocul Surf 2006; 4:62-73. [PMID: 16681077]
11. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear Film Osmolarity: Determination of a Referent for Dry Eye Diagnosis. Invest Ophthalmol Vis Sci 2006; 47:4309-15. [PMID: 17003420]
12. Benelli U, Nardi M, Posarelli C, Albert TG. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Cont Lens Anterior Eye 2010; 33:61-7. [PMID: 20153684]
13. Chen M, Hu DN, Pan Z, Lu CW, Xue CY, Aass I. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways. Exp Eye Res 2010; 90:437-43. [PMID: 20026325]
14. Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 2005; 31:186-93. [PMID: 16163009]
15. Liu H, Begley C, Chen M, Bonanno J, McNamara NA, Nelson JD, Simpson T. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci 2009; 50:3671-9. [PMID: 19324847]
16. Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004; 45:4302-11. [PMID: 15557436]
17. Chen Z, Tong L, Li Z, Yoon KC, Qi H, Farley W, Li DQ, Pflugfelder SC. Hyperosmolarity-induced cornification of human corneal epithelial cells is regulated by JNK MAPK. Invest Ophthalmol Vis Sci 2008; 49:539-49. [PMID: 18234997]
18. Cavet ME, Harrington KL, Ward KW, Zhang JZ. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells. Mol Vis 2010; 16:1791-800. [PMID: 20824100]
19. Suzuki T, Sullivan DA. Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells. Cornea 2005; 24:1004-9. [PMID: 16227852]
20. Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 2007; 26:452-60. [PMID: 17457195]
21. Narayanan S, Miller WL, McDermott AM. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci 2006; 47:2445-50. [PMID: 16723455]
22. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000; 41:1356-63. [PMID: 10798650]
23. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and Anti-inflammatory Forms of Interleukin-1 in the Tear Fluid and Conjunctiva of Patients with Dry-Eye Disease. Invest Ophthalmol Vis Sci 2001; 42:2283-92. [PMID: 11527941]
24. Zoukhri D, Hodges RR, Byon D, Kublin CL. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci 2002; 43:1429-36. [PMID: 11980857]
25. De Paiva CS, Corralesa RM, Villarreala AL, Farley WJ, Li DQ, Stern ME, Pflugfelder SC. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res 2006; 83:526-35. [PMID: 16643899]
26. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A. Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia. J Neurosci 2001; 21:1809-18. [PMID: 11245665]
27. Wang M, Tsai BM, Reiger KM, Brown JW, Meldrum DR. 17-β-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol 2006; 40:205-12. [PMID: 16427650]
28. Hubert A, Cauliez B, Chedeville A, Husson A, Lavoinne A. Osmotic stress, a proinflammatory signal in Caco-2 cells. Biochimie 2004; 86:533-41. [PMID: 15388230]
29. Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1beta, TNFalpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res 2006; 82:588-96. [PMID: 16202406]
30. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee JD. Big mitogen-activated protein kinase 1 (BMK1) is a redoxsensitive kinase. J Biol Chem 1996; 271:16586-90. [PMID: 8663194]
31. Clermont F, Adam E, Dumont JE, Robaye B. Survival pathways regulating the apoptosis induced by tumour necrosis factoralpha in primary cultured bovine endothelial cells. Cell Signal 2003; 15:539-46. [PMID: 12639717]
32. Pan Z, Capó-Aponte JE, Zhang F, Wang Z, Pokorny KS, Reinach PS. Differential dependence of regulatory volume decrease behavior in rabbit corneal epithelial cells on MAPK superfamily activation. Exp Eye Res 2007; 84:978-90. [PMID: 17397832]
33. Niswander JM, Dokas LA. Hyperosmotic stress-induced caspase-3 activation is mediated by p38 MAPK in the hippocampus. Brain Res 2007; 1186:1-11. [PMID: 17996851]
34. Cavet ME, Harrington KL, Ward KW, Zhang JZ. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells. Mol Vis 2010; 16:1791-800. [PMID: 20824100]